ALIM Projected Dividend Yield
Alimera Sciences Inc ( NASDAQ : ALIM )Alimera Sciences is a pharmaceutical company that focuses in the commercialization and development of ophthalmic pharmaceuticals. Co. focuses on diseases affecting the retina. Co.'s commercial product is ILUVIEN®, an intravitreal implant that treats patients by delivering a continuous microdose of the corticosteroid fluocinolone acetonide in the eye, for up to 36 months. ILUVIEN is also used in certain countries in the European Economic Area to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. LUVIEN is inserted into the back of the patient's eye in a non-surgical procedure employing a device with a needle, which allows for a self-sealing wound. 20 YEAR PERFORMANCE RESULTS |
ALIM Dividend History Detail ALIM Dividend News ALIM Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |